ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $624,000 | +83.5% | 173,211 | +36.6% | 0.03% | +63.2% |
| Q2 2019 | $340,000 | +128.2% | 126,811 | +152.1% | 0.02% | +111.1% |
| Q1 2019 | $149,000 | -46.2% | 50,311 | -33.2% | 0.01% | -30.8% |
| Q3 2018 | $277,000 | -59.8% | 75,296 | -59.5% | 0.01% | -53.6% |
| Q1 2018 | $689,000 | +79.9% | 185,913 | +39.7% | 0.03% | +64.7% |
| Q4 2017 | $383,000 | +3.2% | 133,113 | +60.9% | 0.02% | -10.5% |
| Q3 2017 | $371,000 | -38.1% | 82,713 | -36.6% | 0.02% | -40.6% |
| Q2 2017 | $599,000 | +698.7% | 130,550 | +613.4% | 0.03% | +700.0% |
| Q4 2016 | $75,000 | -83.0% | 18,300 | -66.4% | 0.00% | -97.2% |
| Q3 2016 | $440,000 | +22.2% | 54,400 | +16.5% | 0.14% | +787.5% |
| Q1 2016 | $360,000 | -86.8% | 46,679 | -88.2% | 0.02% | -84.2% |
| Q3 2015 | $2,727,000 | +28.9% | 394,723 | +65.2% | 0.10% | +42.3% |
| Q2 2015 | $2,116,000 | +33.6% | 238,879 | +48.7% | 0.07% | +29.1% |
| Q1 2015 | $1,584,000 | -42.8% | 160,678 | -28.9% | 0.06% | -46.6% |
| Q4 2014 | $2,768,000 | -59.8% | 225,971 | -67.2% | 0.10% | -67.6% |
| Q3 2014 | $6,878,000 | +763.0% | 689,243 | +161.0% | 0.32% | +639.5% |
| Q3 2013 | $797,000 | -67.1% | 264,070 | -10.9% | 0.04% | -45.6% |
| Q2 2013 | $2,424,000 | – | 296,374 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |